Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?

INTRODUCTION: Pharmacogenomic studies have used genetic variants to identify smokers likely to respond to pharmacological treatments for smoking cessation. METHODS: We performed a systematic review and meta-analysis of primary and secondary analyses of trials of smoking cessation pharmacotherapies....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nicotine Tob Res
Hlavní autoři: Panagiotou, Orestis A, Schuit, Ewoud, Munafò, Marcus R, Bennett, Derrick A, Bergen, Andrew W, David, Sean P
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6698953/
https://ncbi.nlm.nih.gov/pubmed/30690475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/ntz009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky